Commerce Bancshares Inc
XMUN:CB5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Commerce Bancshares Inc
XMUN:CB5
|
US |
|
Akero Therapeutics Inc
F:0K4
|
US |
|
Cellectis SA
F:ZVAA
|
FR |
|
O
|
Omni Bridgeway Ltd
OTC:IMMFF
|
AU |
|
Perpetual Ltd
OTC:PPTTF
|
AU |
|
E
|
Erdene Resource Development Corp
OTC:ERDCF
|
CA |
Wall St Price Targets
CB5 Price Targets Summary
Commerce Bancshares Inc
According to Wall Street analysts, the average 1-year price target for CB5 is 50.46 EUR with a low forecast of 45.22 EUR and a high forecast of 61.2 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CB5's stock price target?
Price Target
50.46
EUR
According to Wall Street analysts, the average 1-year price target for CB5 is 50.46 EUR with a low forecast of 45.22 EUR and a high forecast of 61.2 EUR.
What is the Revenue forecast for Commerce Bancshares Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Commerce Bancshares Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 6%.
